HNRNPA1 and gastric cancer: In summary, we suggest that RP11‐81H3.2 promotes the GC progression through RP11‐81H3.2‐miR‐339‐HNRNPA1 interaction network, which might provide a novel diagnosis and therapeutic marker for GC treatment.